What is the dose of adrenaline (epinephrine) in emergency situations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline (Epinephrine) Dosing in Emergency Situations

The standard dose of epinephrine in emergency situations is 10 mcg/kg (0.01 mg/kg) for pediatric patients with a maximum single dose of 1 mg, and 1 mg IV/IO every 3-5 minutes for adults during cardiac arrest. 1

Adult Dosing

Cardiac Arrest

  • IV/IO: 1 mg every 3-5 minutes during CPR 1
  • Maximum dose: No specific maximum number of doses, but no survival benefit observed after 10 doses 2
  • If IV/IO access is delayed or cannot be established, endotracheal administration at 2-2.5 mg can be considered 1

Anaphylaxis

  • IM/SC: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) 3
  • May repeat every 5-20 minutes as necessary 1
  • The IM route is preferred for anaphylaxis 1

Pediatric Dosing

Cardiac Arrest

  • IV/IO: 0.01 mg/kg (10 mcg/kg) per dose 1
  • Maximum single dose: 1 mg 1
  • Repeat every 3-5 minutes during resuscitation 1

Specific Age Groups

  • Newborn infants: 0.01-0.03 mg/kg of 1:10,000 solution IV/IO 1
  • Older infants/children: 0.01 mg/kg of 1:10,000 solution (maximum: 1 mg) 1

Anaphylaxis

  • IM/SC: 0.01 mg/kg of 1:1000 solution (maximum: 0.3-0.5 mg) 1
  • May repeat every 5-20 minutes as needed 1
  • For children ≤30 kg: 0.01 mg/kg (0.01 mL/kg), up to 0.3 mg 3
  • For children >30 kg: 0.3-0.5 mg (adult dose) 3

Continuous Infusion Dosing

Shock States

  • Cardiogenic/distributive shock: IV infusion 0.1-1.0 μg/kg/min, titrated to desired clinical effect 1
  • Start at lowest dose and titrate up as needed 1
  • Doses as high as 5 μg/kg/min are sometimes necessary 1

Administration Routes and Concentrations

Available Concentrations

  • 1:1000 (1 mg/mL) - typically used for IM/SC administration 1
  • 1:10,000 (0.1 mg/mL) - typically used for IV/IO administration 1

Route Conversion

  • To convert mg/kg to mL/kg: 0.01 mg/kg = 0.1 mL/kg of 1:10,000 solution 1
  • 0.1 mg/kg = 0.1 mL/kg of 1:1000 solution 1

Important Considerations

Timing of Administration

  • Earlier administration of epinephrine in cardiac arrest is associated with improved outcomes 1, 4
  • For non-shockable rhythms, administer as soon as feasible 1
  • For shockable rhythms, administer after initial defibrillation attempts have been unsuccessful 1

High-Dose vs. Standard-Dose

  • High-dose epinephrine (>10 mcg/kg IV) has not shown increased survival to hospital discharge or improved neurologic outcomes in pediatric cardiac arrest 1
  • In adults, doses >1 mg have not demonstrated improvement in survival to hospital discharge or neurologic outcome 1, 5
  • High-dose epinephrine may be considered in exceptional circumstances such as β-blocker poisoning 1

Potential Adverse Effects

  • May cause tachyarrhythmias, ectopic beats, hypotension, and hypertension 1
  • Extravasation can result in severe skin injury; phentolamine (0.1-0.2 mg/kg up to 10 mg) can be injected intradermally at extravasation site 1
  • In patients with underlying heart disease, may aggravate angina pectoris or produce ventricular arrhythmias 3
  • Patients with hyperthyroidism, Parkinson's disease, diabetes, and pheochromocytoma are at greater risk of adverse reactions 3

Common Pitfalls and Caveats

  • Ensure selection of the appropriate concentration for the route of administration and patient age/condition 1
  • Do not inject into buttocks, digits, hands, or feet 3
  • Monitor for signs of infection at injection sites, as rare cases of serious skin and soft tissue infections have been reported 3
  • The effectiveness of epinephrine decreases with prolonged cardiac arrest, with diminishing returns after multiple doses 2, 6
  • While epinephrine increases rates of ROSC, the impact on neurological outcomes remains uncertain 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.